The model combines human keratinocytes and fibroblasts with a collagen-based or other biomaterial scaffold. This engineered combination creates conditions that support dermal organization and epidermal stratification during culture. The result is a more organized tissue architecture than a simple cell culture, allowing bioengineers to examine structural and functional features under controlled laboratory conditions.
An air-liquid interface is a culture condition used to promote epidermal stratification while supporting dermal organization. These changes help the construct develop layered and organized features associated with skin tissue. Consequently, researchers can study processes such as barrier function and skin development in a model whose environment and composition are defined experimentally.
Controlled composition allows researchers to specify the cellular and biomaterial components present in each construct, while reproducibility supports comparisons between experiments. Together, these properties make it easier to investigate defined changes in skin development, disease mechanisms, or treatment responses. They also provide a controlled alternative to studying intact tissue and can reduce reliance on animal testing.
The organized tissue structure created during culture provides a platform for examining barrier function and wound healing as biological processes. Researchers can study these outcomes within a controlled engineered tissue rather than relying only on intact human skin. This approach supports bioengineering investigations of how skin structure relates to function and repair.
Construction begins by combining human keratinocytes and fibroblasts with a collagen-based or other biomaterial scaffold. The developing construct is then maintained under culture conditions selected to promote dermal organization and epidermal stratification, including an air-liquid interface. These steps produce a reproducible engineered tissue suitable for subsequent developmental, functional, or response studies.
Applications include research on skin development, barrier function, wound healing, and disease mechanisms. The same platform can also support studies of how skin responds to pharmaceuticals or cosmetic ingredients. Because researchers control the construct's composition and culture environment, they can use one model system to address several related biological and applied questions.
The construct provides an engineered tissue context in which responses to pharmaceuticals or cosmetic ingredients can be studied under controlled conditions. Its defined cellular composition and reproducible culture system help researchers compare treatment-related effects across experiments. This use expands evaluation beyond isolated cellular observations while offering an alternative approach that can reduce reliance on animal testing.
In bioengineering, the model demonstrates how human cells, biomaterial scaffolds, and culture conditions can be combined to recreate important tissue features. Its applications in engineered skin and regenerative medicine connect tissue construction with functional research on development, repair, and disease. The approach therefore supports both investigation of skin biology and development of engineered tissue strategies.